Delivery Order SPE2DB20D3101-SPE2DB24FRBJ7
Award Date
2/12/24
Potential Completion Date
2/13/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,051.68 and a completion date of June 13, 2025. The award is for the supply of the drug NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with the ID SPE2DX15D1104|SPE2DX24F3JK1, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,268.66 firm fixed-price delivery order is for the pharmaceutical product NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, with a completion date of December 22, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEKV1, valued at $2,638.47, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This firm fixed price delivery order is for the supply of 4564230198 NAROPIN 0.5% 150 MG/30 ML VIAL 30ML to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp, which has a potential value of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, with a ceiling value of $1,181.78 and a period of performance through February 21, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition....
This federal contract award with ID SPE2DB22D3301|SPE2DB25FX7MN was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,537.58 firm fixed-price delivery order is for the supply of NAROPIN 1% 200 MG/20 ML VIAL 20ML, a medication used for pain management. This award is not associated with any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,666.54 for the supply of 4556458420 - Naropin 0.2% 400 mg/200 ml bottles. The contract was awarded on March 4, 2022 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of March 7, 2022. The contract type is Firm Fixed Price. There is no set-aside designation indicated for this award. Amerisourcebergen is a major pharmaceutical distributor that...
This federal contract award is for the delivery of Naropin 0.5% 150 mg/30 ml vials to the Defense Logistics Agency (DLA), a defense agency. The $2,331.68 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 13, 2024, with a completion date of December 16, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,624.76 firm fixed-price delivery order is for the supply of a generic anesthetic medication, Naropin 0.5% 150 mg/30 ml vial. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 150 mg/20 ml vials of the pharmaceutical product NAROPIN 0.75% in support of military treatment programs and facilities. The order has a potential value of $1,580.06 and a completion date of January 24, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime...